company background image
CARE

Dialogue Health Technologies TSX:CARE Stock Report

Last Price

CA$2.47

Market Cap

CA$163.5m

7D

3.1%

1Y

-64.3%

Updated

04 Oct, 2022

Data

Company Financials +
CARE fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

CARE Stock Overview

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada Germany, and Australia.

Rewards

Earnings are forecast to grow 77.68% per year

Trading below our calculated fair Price-To-Sales ratio

Risk Analysis

No risks detected for CARE from our risk checks.

Dialogue Health Technologies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dialogue Health Technologies
Historical stock prices
Current Share PriceCA$2.47
52 Week HighCA$8.85
52 Week LowCA$2.17
Beta0
1 Month Change-14.71%
3 Month Change-2.95%
1 Year Change-64.28%
3 Year Changen/a
5 Year Changen/a
Change since IPO-82.71%

Recent News & Updates

Jun 28
An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Today we will run through one way of estimating the intrinsic value of Dialogue Health Technologies Inc. ( TSE:CARE...

Shareholder Returns

CARECA HealthcareCA Market
7D3.1%2.5%5.7%
1Y-64.3%-33.4%-2.5%

Return vs Industry: CARE underperformed the Canadian Healthcare industry which returned -33.2% over the past year.

Return vs Market: CARE underperformed the Canadian Market which returned -4% over the past year.

Price Volatility

Is CARE's price volatile compared to industry and market?
CARE volatility
CARE Average Weekly Movement12.0%
Healthcare Industry Average Movement8.4%
Market Average Movement10.1%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market3.8%

Stable Share Price: CARE is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: CARE's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016270Cherif Habibhttps://dialogue.co

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company’s platform also enables its members and their dependents to access employee assistance, and occupational health and safety programs.

Dialogue Health Technologies Fundamentals Summary

How do Dialogue Health Technologies's earnings and revenue compare to its market cap?
CARE fundamental statistics
Market CapCA$163.52m
Earnings (TTM)-CA$28.90m
Revenue (TTM)CA$79.88m

2.0x

P/S Ratio

-5.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CARE income statement (TTM)
RevenueCA$79.88m
Cost of RevenueCA$44.10m
Gross ProfitCA$35.77m
Other ExpensesCA$64.67m
Earnings-CA$28.90m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.44
Gross Margin44.79%
Net Profit Margin-36.18%
Debt/Equity Ratio1.2%

How did CARE perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is CARE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CARE?

Other financial metrics that can be useful for relative valuation.

CARE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.3x
Enterprise Value/EBITDA-3.8x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CARE's PS Ratio compare to its peers?

CARE PS Ratio vs Peers
The above table shows the PS ratio for CARE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.9x
QIPT Quipt Home Medical
1.1x24.7%CA$195.6m
AKU Akumin
0.3x9.4%CA$238.1m
GTMS Greenbrook TMS
1.6x38.3%CA$117.8m
DOC CloudMD Software & Services
0.5x4.5%CA$79.3m
CARE Dialogue Health Technologies
2x20.4%CA$163.5m

Price-To-Sales vs Peers: CARE is expensive based on its Price-To-Sales Ratio (2x) compared to the peer average (0.9x).


Price to Earnings Ratio vs Industry

How does CARE's PE Ratio compare vs other companies in the CA Healthcare Industry?

Price-To-Sales vs Industry: CARE is expensive based on its Price-To-Sales Ratio (2x) compared to the Canadian Healthcare industry average (0.9x)


Price to Sales Ratio vs Fair Ratio

What is CARE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CARE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2x
Fair PS Ratio2.2x

Price-To-Sales vs Fair Ratio: CARE is good value based on its Price-To-Sales Ratio (2x) compared to the estimated Fair Price-To-Sales Ratio (2.2x).


Share Price vs Fair Value

What is the Fair Price of CARE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CARE (CA$2.47) is trading above our estimate of fair value (CA$1.73)

Significantly Below Fair Value: CARE is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is Dialogue Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


77.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CARE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.6%).

Earnings vs Market: CARE is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CARE is expected to become profitable in the next 3 years.

Revenue vs Market: CARE's revenue (20.4% per year) is forecast to grow faster than the Canadian market (5.7% per year).

High Growth Revenue: CARE's revenue (20.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CARE's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Dialogue Health Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-32.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CARE is currently unprofitable.

Growing Profit Margin: CARE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CARE is unprofitable, and losses have increased over the past 5 years at a rate of 32.1% per year.

Accelerating Growth: Unable to compare CARE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CARE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-34.2%).


Return on Equity

High ROE: CARE has a negative Return on Equity (-27.13%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Dialogue Health Technologies's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: CARE's short term assets (CA$82.5M) exceed its short term liabilities (CA$20.1M).

Long Term Liabilities: CARE's short term assets (CA$82.5M) exceed its long term liabilities (CA$2.9M).


Debt to Equity History and Analysis

Debt Level: CARE has more cash than its total debt.

Reducing Debt: Insufficient data to determine if CARE's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CARE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CARE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Dividend

What is Dialogue Health Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Dialogue Health Technologies Dividend Yield vs Market
How does Dialogue Health Technologies dividend yield compare to the market?
SegmentDividend Yield
Company (Dialogue Health Technologies)n/a
Market Bottom 25% (CA)1.9%
Market Top 25% (CA)5.9%
Industry Average (Healthcare)4.5%
Analyst forecast in 3 Years (Dialogue Health Technologies)n/a

Notable Dividend: Unable to evaluate CARE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CARE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CARE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CARE's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CARE has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Cherif Habib (40 yo)

6.25yrs

Tenure

CA$975,000

Compensation

Mr. Cherif Habib is a Co-founder of Dialogue Health Technologies Inc. (formerly known as Dialogue Technologies Inc.) and has been its Chief Executive Officer since 2016 and has been its Director since July...


CEO Compensation Analysis

Cherif Habib's Compensation vs Dialogue Health Technologies Earnings
How has Cherif Habib's remuneration changed compared to Dialogue Health Technologies's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-CA$29m

Mar 31 2022n/an/a

-CA$27m

Dec 31 2021CA$975kCA$300k

-CA$251m

Sep 30 2021n/an/a

-CA$251m

Jun 30 2021n/an/a

-CA$251m

Mar 31 2021n/an/a

-CA$247m

Dec 31 2020CA$300kCA$300k

-CA$21m

Compensation vs Market: Cherif's total compensation ($USD719.02K) is above average for companies of similar size in the Canadian market ($USD178.56K).

Compensation vs Earnings: Cherif's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: CARE's management team is considered experienced (2.3 years average tenure).


Board Members

Experienced Board: CARE's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

TSX:CARE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Jun 22BuyCA$5,200Alexis SmirnovIndividual1,300CA$4.00
01 Dec 21BuyCA$48,289,154Sun Life Financial Inc.Company6,036,144CA$8.00

Ownership Breakdown

What is the ownership structure of CARE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,610,9258.5%
Institutions7,332,36511.1%
VC/PE Firms15,201,41722.9%
Public Companies15,211,57122.9%
General Public22,980,68634.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 19 shareholders own 65.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.93%
Sun Life Financial Inc.
15,211,571CA$37.5m0%no data
13.01%
White Star Capital, L.P.
8,628,223CA$21.3m0%no data
9.91%
HV Capital Adviser GmbH
6,573,194CA$16.2m0%100%
9.49%
Caisse de dépôt et placement du Québec
6,293,673CA$15.5m0%0.01%
5.4%
Cherif Habib
3,583,599CA$8.8m0%no data
3%
Alexis Smirnov
1,988,498CA$4.9m0.07%no data
0.81%
FMR LLC
535,000CA$1.3m0%no data
0.32%
Portage Ventures L.P.
211,856CA$522.2k0%no data
0.2%
Manulife Asset Management
132,734CA$327.2k-10.13%no data
0.098%
Sectoral Asset Management Inc.
65,187CA$160.7k0%0.01%
0.068%
Formula Growth Limited
45,413CA$111.9k0%0.02%
0.039%
1832 Asset Management L.P.
25,559CA$63.0k0%no data
0.033%
CI Global Asset Management
21,649CA$53.4k6.23%no data
0.029%
Norma Beauchamp
19,246CA$47.4k352.85%no data
0.023%
Jean-Nicolas Guillemette
15,416CA$38.0k0%no data
0.0063%
Nathalie Delisle
4,166CA$10.3k0%no data
0.001%
Professionals Financial Inc.
679CA$1.7k0%no data
0.00067%
Professionals' Financial - Mutual Funds Inc.
445CA$1.1k0%no data
0.00026%
Dimensional Fund Advisors LP
170CA$419.00%no data

Company Information

Dialogue Health Technologies Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Dialogue Health Technologies Inc.
  • Ticker: CARE
  • Exchange: TSX
  • Founded: 2016
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: CA$163.521m
  • Shares outstanding: 66.34m
  • Website: https://dialogue.co

Number of Employees


Location

  • Dialogue Health Technologies Inc.
  • 390 Notre-Dame Street West
  • Suite 200
  • Montreal
  • Quebec
  • H2Y 1T9
  • Canada


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CARETSX (The Toronto Stock Exchange)YesCommon SharesCACADMar 2021
DLHT.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMar 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/04 00:00
End of Day Share Price2022/10/04 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.